MENA Vaccine Market Expected to Reach USD 3.8 Billion by 2033 - IMARC Group

MENA Vaccine Market Statistics, Outlook and Regional Analysis 2025-2033

The MENA vaccine market size was valued at USD 2.3 Billion in 2024, and it is expected to reach USD 3.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.7% from 2025 to 2033.

Newly launched campaigns focus on collaboration among health agencies to improve accessibility, emphasizing school-aged children and supporting community health through mass immunization programs. For example, in June 2024, the Ministry of Health, UNICEF, and WHO introduced a national vaccination program to protect children from diseases like measles and rubella, in Basra, Iraq. This USAID-funded project reached out to about 7.5 million children aged 6 to 12 who attended primary schools and kindergartens. 

Moreover, despite the difficult circumstances, efforts are being made in conflict-prone areas to ensure that children receive life-saving vaccines, such as polio. These initiatives rely on stability because health workers want to protect vulnerable populations. For instance, in August 2024, the United Nations Relief and Works Agency for Palestine Refugees (UNRWA) initiated a polio immunization program in the Gaza Strip. The Gaza Health Ministry appealed to end hostilities to ensure the campaign's success. Furthermore, MENA vaccine manufacturers are increasing their portfolios by producing region-specific vaccinations against illnesses, like MERS-CoV and hepatitis. For example, Saudi Arabia collaborated with local and foreign pharmaceutical companies to produce MERS-CoV vaccinations for specific health problems. Similarly, Egypt's engagement with Sinovac for domestic COVID-19 vaccine manufacturing has fulfilled local needs and established the country as a supplier to other African countries.

MENA Vaccine Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Saudi Arabia, Turkey, Israel, United Arab Emirates, Egypt, Iran, Iraq, Qatar, Algeria, Kuwait, Morocco, Oman, and others. These regions focus on spreading awareness among individuals towards the importance of vaccination programs.

Saudi Arabia Vaccine Market Trends:

Saudi Arabia emphasizes immunization during religious gatherings, particularly Hajj and Umrah. The Ministry of Health requires pilgrims to receive meningococcal vaccinations, as well as healthcare staff to be immunized against hepatitis A and B. Its strong National Immunization Program promotes wider vaccination delivery.

Turkey Vaccine Market Trends:

Turkey's National Vaccine Program revolves around immunization against illnesses, including diphtheria and tetanus. The country also manufactures vaccines domestically, with facilities such as Kocak Farma producing hepatitis and influenza vaccines. Its collaboration with WHO on polio eradication campaigns illustrates its commitment to combating infectious illnesses through vigorous vaccination drives.

Israel Vaccine Market Trends:

Israel was among the first to implement countrywide COVID-19 vaccinations. It employs modern digital health technologies to monitor vaccination distribution. Israel's engagement with Pfizer to assess the effectiveness of the COVID-19 vaccine emphasizes the country's status as a global leader in healthcare data integration.

United Arab Emirates Vaccine Market Trends:

The UAE supports vaccine accessibility through free immunization campaigns and enhanced cold-chain logistics. Dubai's Vaccine Logistics Alliance facilitates the global delivery of COVID-19 vaccinations. Furthermore, the UAE's clinical studies for the Sinopharm vaccine demonstrate its dedication to global health efforts and regional vaccine availability.

Egypt Vaccine Market Trends:

Egypt is increasing its vaccine production capacity by making Sinovac COVID-19 vaccines locally. Its Vaccine for Africa initiative attempts to provide vaccines regionally. Egypt's commitment to preventing hepatitis C through nationwide vaccination programs highlights its leadership in addressing regional health concerns.

Iran Vaccine Market Trends:

Iran is working toward self-sufficiency in vaccine production, with institutes, like the Razi Vaccine and Serum Research Institute producing vaccinations for illnesses, including polio and anthrax. Iran also produced its COVID-19 vaccine, COVIran Barekat, demonstrating its dedication to local innovation amid global supply constraints.

Iraq Vaccine Market Trends:

Iraq's vaccination initiatives are aimed at reconstructing the immunization infrastructure that has been destroyed by violence. National programs against polio and measles strive to increase coverage, particularly among displaced people. Partnerships with UNICEF and WHO improve vaccination distribution, emphasizing international collaboration to address logistical and healthcare system limitations.

Qatar Vaccine Market Trends:

Qatar encourages public-private collaborations in vaccinations. It partners with organizations like Sidra Medicine to improve pediatric vaccination programs. Qatar's fast COVID-19 vaccine deployment, supported by its modern healthcare infrastructure, demonstrates its capacity to handle large-scale immunization operations efficiently.

Algeria Vaccine Market Trends:

Algeria supports children being vaccinated to prevent illnesses, like measles, polio, and TB. The country's engagement with the WHO on measles eradication demonstrates its commitment to combatting avoidable diseases. Its continued efforts to upgrade vaccination distribution methods are improving accessibility in both urban and rural locations.

Kuwait Vaccine Market Trends:

Kuwait concentrates on influenza and pneumococcal vaccinations for its older population. The Ministry of Health also carried out a successful national COVID-19 immunization program. Kuwait's emphasis on targeted vaccination measures for vulnerable groups shows its customized approach to meeting population-specific healthcare requirements.

Morocco Vaccine Market Trends:

Morocco excels at vaccine accessibility and public awareness efforts. It started Africa's first statewide COVID-19 immunization campaign, focusing on high-risk groups. Morocco's partnership with worldwide groups to increase rural vaccination rates demonstrates its commitment to balanced vaccine distribution.

Oman Vaccine Market Trends:

With one of the region's highest vaccination rates, Oman promotes illness prevention through regular vaccines. For example, Oman has been free of polio since 1993 due to strong national vaccination programs and partnership with the World Health Organization. The country's efficient healthcare infrastructure also meant that its COVID-19 immunization campaign was implemented quickly, prioritizing high-risk groups.

Other MENA Countries Vaccine Market Trends:

Other MENA countries, such as Lebanon, Jordan, and Tunisia, are prioritizing vaccination despite economic problems. Lebanon, for example, focuses on polio eradication in refugee camps via UNICEF-led initiatives. Jordan collaborates with WHO to increase vaccination accessibility for its rising population, which includes refugees.

Top Companies Leading in the MENA Vaccine Industry

Some of the leading MENA vaccine market companies have been provided in the report. They are developing vaccinations by investing extensively in R&D activities to mitigate numerous diseases. In addition, they are also focusing on streamlining regulatory approval processes. Furthermore, the inflating healthcare infrastructures across countries will continue to bolster the market in the coming years.

MENA Vaccine Market Segmentation Coverage

• Based on the product type, the market has been segmented into multivalent vaccine and monovalent vaccine. Monovalent vaccines target a single antigen to battle specific illnesses, and multivalent vaccines provide broader protection against several antigens.
• Based on the treatment type, the market has been categorized into preventive vaccine and therapeutic vaccine. Preventive vaccines aim to prevent illness through immunization programs, and therapeutic vaccines treat existing disorders by increasing immunity.
• Based on the technology, the market has been divided into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, and others. Conjugate vaccines boost immunogenicity against bacterial infections, inactivated and subunit vaccines provide safety by using non-live components, live attenuated vaccines provide strong and long-lasting immunity, recombinant vaccines use genetic engineering for precision, and toxoid vaccines target toxin-induced diseases.
• Based on the route of administration, the market has been classified into intramuscular and subcutaneous administration, oral administration, and others. Intramuscular and subcutaneous administration ensures effective delivery and strong immune responses, especially for systemic infections. Oral administration is used for convenience and mass vaccination against gastrointestinal disorders, like rotavirus.
• Based on the patient type, the market has been segmented into pediatric and adult. Pediatric vaccines focus on protecting children from diseases, like measles and polio, while adult vaccines prioritize flu, hepatitis, and COVID-19 prevention.
• Based on the indication, the market has been categorized into bacterial diseases (meningococcal disease, pneumococcal disease, diphtheria/tetanus/pertussis (DPT), tuberculosis, haemophilus influenzae (Hib), typhoid, and others) and viral diseases (hepatitis, influenza, human papillomavirus (HPV), measles/mumps/rubella (MMR), rotavirus, herpes zoster, varicella, Japanese encephalitis, rubella, polio, rabies, dengue, and others). Bacterial vaccines treat diseases such as pneumococcal infections and meningitis. However, viral vaccines treat illnesses, including influenza, hepatitis, and COVID-19.
• Based on the distribution channel, the market has been divided into hospital pharmacies, retail pharmacies, institutional sales, and others. Vaccination programs and critical care are mostly delivered through hospital pharmacies. Retail pharmacies improve accessibility for individual consumers, whereas institutional sales help the government and large-scale vaccination programs.
• Based on the end user, the market has been classified into hospitals, clinics, vaccination centers, academic and research institutes, and others. Hospitals provide comprehensive immunization treatments. Clinics provide regular vaccines in local areas. Vaccination centers facilitate major immunization campaigns. Academic and research institutes concentrate on vaccine development.

Browse IMARC Related Reports on Vaccine Market:

• Indian Vaccine Market Report
   
• Vaccine Market Report
   
• GCC Vaccine Market Report
   
• East Africa Vaccine Market Report
   
• Vietnam Vaccine Market Report